Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

China YTC Will Merge Subsidiary with Supplier

publication date: Apr 11, 2008

China YCT International Group Inc. (OTCBB: CYIG) announced an unusually complex agreement between its China subsidiary, Shandong Spring Pharmaceutical Co., Ltd, and a second company with which it shares some history, Shandong Yong Chun Tang Bioengineering Co. Ltd. The two companies have signed an Entrusted Management Agreement under which Shandong Spring will manage the operations of Shandong Yong Chun Tang in exchange for all of the latter’s net profits. More details...

Stock Symbol: (OTCBB: CYIG)



Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital